Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Lysin-spezifische Methyltransferase 2D

Das KMT2D-Gen kodiert eine Methyltransferase für Histon H3, welche an der Transkriptionskontrolle beteiligt ist. Mutationen führen zum autosomal dominanten Kabuki-Syndrom 1.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Kabuki-Syndrom 1
KMT2D

Referenzen:

1.

Miyake N et al. (2013) MLL2 and KDM6A mutations in patients with Kabuki syndrome.

external link
2.

Toska E et al. (2017) PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.

external link
3.

Li Y et al. (2016) Structural basis for activity regulation of MLL family methyltransferases.

external link
4.

Zhu J et al. (2015) Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.

external link
5.

Lee JE et al. (2013) H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.

external link
6.

Morin RD et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.

external link
7.

Parsons DW et al. (2011) The genetic landscape of the childhood cancer medulloblastoma.

external link
8.

Karlin S et al. (2002) Associations between human disease genes and overlapping gene groups and multiple amino acid runs.

external link
9.

Karlin S et al. (2002) Amino acid runs in eukaryotic proteomes and disease associations.

external link
10.

Banka S et al. (2012) How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum.

external link
11.

Hannibal MC et al. (2011) Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.

external link
12.

Li Y et al. (2011) A mutation screen in patients with Kabuki syndrome.

external link
13.

Ng SB et al. (2010) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome.

external link
14.

Van Laarhoven PM et al. (2015) Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.

external link
15.

Micale L et al. (2014) Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients.

external link
16.

Prasad R et al. (1997) Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax.

external link
17.

NCBI article

NCBI 8085 external link
18.

OMIM.ORG article

Omim 602113 external link
19.

Orphanet article

Orphanet ID 239011 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz